ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Hebei Medical University Fourth Hospital
National Cancer Institute (NCI)
Yonsei University
Second Affiliated Hospital, School of Medicine, Zhejiang University
LARKSPUR BIOSCIENCES, INC.
Hunan Province Tumor Hospital
Universitaire Ziekenhuizen KU Leuven
Guangdong Provincial People's Hospital
Shanghai JMT-Bio Inc.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Case Comprehensive Cancer Center
Beijing Friendship Hospital
Sixth Affiliated Hospital, Sun Yat-sen University
Tang-Du Hospital
Sun Yat-sen University
NYU Langone Health
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
Ruijin Hospital
IMGT Co., Ltd.
Shandong Provincial Hospital
Alliance for Clinical Trials in Oncology
Fudan University
UNICANCER
Università Vita-Salute San Raffaele
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Genfleet Therapeutics (Shanghai) Inc.
Sichuan University
Women's Hospital School Of Medicine Zhejiang University
First Affiliated Hospital of Wenzhou Medical University
Shandong Cancer Hospital and Institute
First Affiliated Hospital of Chongqing Medical University
Indiana University
Harbin Medical University
The First Affiliated Hospital with Nanjing Medical University
Shanghai Pulmonary Hospital, Shanghai, China
Trans Tasman Radiation Oncology Group
Guangdong Association of Clinical Trials
National Cancer Center, China
Peking Union Medical College Hospital
Shengjing Hospital
Guangzhou University of Traditional Chinese Medicine
Institut du Cancer de Montpellier - Val d'Aurelle
West China Hospital
Mansoura University
Fujian Cancer Hospital
Shanghai Gynecologic Oncology Group